Sodium;N-(chloromethoxymethyl)-4-(6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)aniline;[4-(7-chloro-6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)anilino]methoxymethyl acetate;1-chloropyrrolidine-2,5-dione;acetate
C34H37Cl3N11NaO8 — CID 157364647
Data last refreshed: (MolForge compound catalog, from PubChem)
About Sodium;N-(chloromethoxymethyl)-4-(6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)aniline;[4-(7-chloro-6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)anilino]methoxymethyl acetate;1-chloropyrrolidine-2,5-dione;acetate
Sodium;N-(chloromethoxymethyl)-4-(6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)aniline;[4-(7-chloro-6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)anilino]methoxymethyl acetate;1-chloropyrrolidine-2,5-dione;acetate (PubChem CID 157364647) has the molecular formula C34H37Cl3N11NaO8 and a molecular weight of 857.09 g/mol. Its IUPAC name is sodium;N-(chloromethoxymethyl)-4-(6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)aniline;[4-(7-chloro-6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)anilino]methoxymethyl acetate;1-chloropyrrolidine-2,5-dione;acetate.
Molecular Properties
| Compound Name | Sodium;N-(chloromethoxymethyl)-4-(6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)aniline;[4-(7-chloro-6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)anilino]methoxymethyl acetate;1-chloropyrrolidine-2,5-dione;acetate |
|---|---|
| PubChem CID | 157364647 |
| Molecular Formula | C34H37Cl3N11NaO8 |
| Molecular Weight | 857.09 g/mol |
| Exact Mass | 855.18 |
| IUPAC Name | sodium;N-(chloromethoxymethyl)-4-(6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)aniline;[4-(7-chloro-6-methyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)anilino]methoxymethyl acetate;1-chloropyrrolidine-2,5-dione;acetate |
| SMILES | CC(=O)OCOCNc1ccc(-c2nc3c(Cl)c(C)[nH]n3n2)cc1.CC(=O)[O-].Cc1cc2nc(-c3ccc(NCOCCl)cc3)nn2[nH]1.O=C1CCC(=O)N1Cl.[Na+] |
| InChI | InChI=1S/C15H16ClN5O3.C13H14ClN5O.C4H4ClNO2.C2H4O2.Na/c1-9-13(16)15-18-14(20-21(15)19-9)11-3-5-12(6-4-11)17-7-23-8-24-10(2)22;1-9-6-12-16-13(18-19(12)17-9)10-2-4-11(5-3-10)15-8-20-7-14;5-6-3(7)1-2-4(6)8;1-2(3)4;/h3-6,17,19H,7-8H2,1-2H3;2-6,15,17H,7-8H2,1H3;1-2H2;1H3,(H,3,4);/q;;;;+1/p-1 |
| InChIKey | IASMVJJZEKKZDG-UHFFFAOYSA-M |
| XLogP | 1.26 |
| TPSA | 238.29 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 857.09 |
| LogP ≤ 5 | 1.26 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'N-halo', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157364647 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.